Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

The release of COVID-19 vaccine results days after the 2020 election may have not been a "coincidence" -- and could have been part of an effort by senior Pfizer executives to "deliberately slow ...

The newest, updated Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are now available at pharmacies and clinics. The Novavax recombinant protein vaccine should be available soon.

Pfizer did not tell the truth about their COVID-19 vaccines." In all, Paxton's 54-page complaint acts as a compendium of pandemic-era anti-vaccine misinformation and tropes while making a slew of ...

WASHINGTON — Pfizer’s COVID-19 pill appears to provide little or no benefit for adults under 65 while still reducing the risk of hospitalization and death for high-risk seniors, according to a ...